Citation Impact
Citing Papers
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
2002
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder
2003 Standout
Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients
2009
Outcome in the Pharmacologic Treatment of Bipolar Disorder
1996
Alzheimer's disease in Down syndrome: Neurobiology and risk
2007
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
Rivastigmine for Alzheimer's disease
2000
Neurobiology of Depression
2002 Standout
Evaluation of the antidepressant activity of Moringa oleifera alone and in combination with fluoxetine
2015 Standout
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Major Depressive Disorder
2008 Standout
Dopamine and depression
1993
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
GABAergic dysfunction in mood disorders
2003
Health Supervision for Children With Down Syndrome
2011 Standout
Subcortical ischaemic vascular dementia
2002 Standout
Maintenance therapies for classic and other forms of bipolar disorder
2000
Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia
1997
Parkinson's Disease
2003 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
1998
Prophylaxis of Bipolar Affective Disorders
1990
A catechol- O -methyltransferase that is essential for auditory function in mice and humans
2008 StandoutNobel
Alzheimer Disease as a Vascular Disorder
2002
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
1992 Standout
Rivastigmine for Alzheimer's disease
2015
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Works of S Puźyński being referenced
Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders.
1984
Apolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia
2000
Valproic acid amide in the treatment of affective and schizoaffective disorders
1984
Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness
1983
An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting.
2002
Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness
1983
Disturbances in tryptophan and serotonin metabolism in affective psychoses and schizophrenia.
1975
[GABA levels in the plasma of patients with endogenous depression and during the treatment with thymoleptics].
1992
Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness
1983
Failure to correlate urinary MHPG with clinical response to amitriptyline
1984